These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9193197)

  • 1. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
    Gabriel SM; Haroutunian V; Powchik P; Honer WG; Davidson M; Davies P; Davis KL
    Arch Gen Psychiatry; 1997 Jun; 54(6):559-66. PubMed ID: 9193197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.
    Honer WG; Falkai P; Young C; Wang T; Xie J; Bonner J; Hu L; Boulianne GL; Luo Z; Trimble WS
    Neuroscience; 1997 May; 78(1):99-110. PubMed ID: 9135092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
    Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
    Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains.
    Davidsson P; Gottfries J; Bogdanovic N; Ekman R; Karlsson I; Gottfries CG; Blennow K
    Schizophr Res; 1999 Nov; 40(1):23-9. PubMed ID: 10541003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
    Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
    Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
    Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
    Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay.
    Siew LK; Love S; Dawbarn D; Wilcock GK; Allen SJ
    J Neurosci Methods; 2004 Oct; 139(2):153-9. PubMed ID: 15488227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
    Minger SL; Honer WG; Esiri MM; McDonald B; Keene J; Nicoll JA; Carter J; Hope T; Francis PT
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):929-36. PubMed ID: 11589423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia.
    Narr KL; Toga AW; Szeszko P; Thompson PM; Woods RP; Robinson D; Sevy S; Wang Y; Schrock K; Bilder RM
    Biol Psychiatry; 2005 Jul; 58(1):32-40. PubMed ID: 15992520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
    Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T
    J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.
    Ramos-Miguel A; Beasley CL; Dwork AJ; Mann JJ; Rosoklija G; Barr AM; Honer WG
    Biol Psychiatry; 2015 Sep; 78(6):361-73. PubMed ID: 25662103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
    Glantz LA; Lewis DA
    Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.
    Reddy PH; Mani G; Park BS; Jacques J; Murdoch G; Whetsell W; Kaye J; Manczak M
    J Alzheimers Dis; 2005 Apr; 7(2):103-17; discussion 173-80. PubMed ID: 15851848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.
    Masliah E; Terry RD; DeTeresa RM; Hansen LA
    Neurosci Lett; 1989 Aug; 103(2):234-9. PubMed ID: 2505201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material.
    Clinton J; Blackman SE; Royston MC; Roberts GW
    Neuroreport; 1994 Jan; 5(4):497-500. PubMed ID: 8003683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Osimo EF; Beck K; Reis Marques T; Howes OD
    Mol Psychiatry; 2019 Apr; 24(4):549-561. PubMed ID: 29511299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.
    Perrone-Bizzozero NI; Sower AC; Bird ED; Benowitz LI; Ivins KJ; Neve RL
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14182-7. PubMed ID: 8943081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease.
    Brion JP; Couck AM; Bruce M; Anderton B; Flament-Durand J
    Brain Res; 1991 Jan; 539(1):143-50. PubMed ID: 1901750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.
    Egbujo CN; Sinclair D; Borgmann-Winter KE; Arnold SE; Turetsky BI; Hahn CG
    Schizophr Res; 2015 Oct; 168(1-2):554-62. PubMed ID: 26260078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.